Gene · 429
Papers4,495
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 4,495
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Direct Neural Reprogramming in situ: Existing Approaches and Their Optimization. | Biochemistry (Mosc) | 2025 | 40254400 | PubTator, text mining | PubMed |
| A circular RNA in neuroendocrine carcinomas. | Cancer Cell | 2025 | 40250442 | PubTator, text mining | PubMed |
| Challenges of small cell lung cancer heterogeneity and phenotypic plasticity. | Nat Rev Cancer | 2025 | 40211072 | PubTator, text mining | PubMed |
| A semi-supervised weighted SPCA- and convolution KAN-based model for drug response prediction. | Front Genet | 2025 | 40191608 | PubTator, text mining | PubMed |
| Ascl1-mediated enhancement of GABAergic neuronal function in differentiated F11 cells under high glucose conditions. | Biochem Biophys Res Commun | 2025 | 40168711 | PubTator, text mining | PubMed |
| New insights into markers for distinguishing neuroendocrine prostate cancer: evidence from single-cell analysis. | Front Immunol | 2025 | 40165961 | PubTator, text mining | PubMed |
| Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation. | Cancer Metab | 2025 | 40165271 | PubTator, text mining | PubMed |
| Comparative profiling of surgically resected primary tumors and their lymph node metastases in small-cell lung cancer. | ESMO Open | 2025 | 40107154 | PubTator, text mining | PubMed |
| Targeting the histone reader ZMYND8 inhibits antiandrogen-induced neuroendocrine tumor transdifferentiation of prostate cancer. | Nat Cancer | 2025 | 40102673 | PubTator, text mining | PubMed |
| Lethal co-expression intolerance underlies the mutually exclusive expression of ASCL1 and NEUROD1 in SCLC cells. | NPJ Precis Oncol | 2025 | 40082639 | PubTator, text mining | PubMed |
| Harnessing Intelligence from Brain Cells In Vitro. | Neuroscientist | 2025 | 40079153 | PubTator, text mining | PubMed |
| Pharmacological inhibition of the Janus Kinases enhances ASCL1 protein stability and transcriptional activity. | Mol Biol Rep | 2025 | 40072659 | PubTator, text mining | PubMed |
| Retrovirus-Mediated Reprogramming of Endogenous Hippocampal Glia into GABAergic Induced Neurons. | Methods Mol Biol | 2025 | 40067626 | PubTator, text mining | PubMed |
| KSR2 Promotes Self-Renewal and Clonogenicity of Small Cell Lung Carcinoma. | Mol Cancer Res | 2025 | 40063515 | PubTator, text mining | PubMed |
| Defined cellular reprogramming of androgen receptor-active prostate cancer to neuroendocrine prostate cancer. | bioRxiv | 2025 | 40027790 | PubTator, text mining | PubMed |
| Integrative spatial analysis reveals tumor heterogeneity and immune colony niche related to clinical outcomes in small cell lung cancer. | Cancer Cell | 2025 | 39983726 | PubTator, text mining | PubMed |
| Sex-based differences in the long-term fate of hippocampal neurons born after a traumatic brain injury. | Front Behav Neurosci | 2025 | 39974293 | PubTator, text mining | PubMed |
| An integrative analysis of ASCL1 in breast cancer and inhibition of ASCL1 increases paclitaxel sensitivity by activating ferroptosis via the CREB1/GPX4 axis. | Front Immunol | 2025 | 39963143 | PubTator, text mining | PubMed |
| The Potential of Single-Transcription Factor Gene Expression by RT-qPCR for Subtyping Small Cell Lung Cancer. | Int J Mol Sci | 2025 | 39941061 | PubTator, text mining | PubMed |
| KSR1 Mediates Small Cell Lung Carcinoma Tumor Initiation and Cisplatin Resistance. | Mol Cancer Res | 2025 | 39927878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/429/papers?page=13